Menopause Market Report Provides Insights Into Market Evolution And Growth Prospects

The menopause market is on track for impressive growth in the coming years, driven by evolving healthcare approaches and increased awareness around women's health. As more women seek effective and safer treatment options, the industry is adapting with new innovations and expanding access through digital platforms and online pharmacies. Let's explore the market's size, key drivers, leading companies, emerging trends, and important segments shaping its future.

Projected Market Value and Growth Trajectory in the Menopause Market
The menopause market is expected to reach $26.21 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.1%. This robust expansion is fueled by a rising preference for safer, long-term treatment options, the surge of menopause-focused digital health services, a growing emphasis on preventive care specifically tailored for women, broader availability of online pharmacies, and greater acceptance of alternative and lifestyle-based therapies. Key trends anticipated during this period include increased use of non-hormonal treatments, heightened awareness around menopause management, a stronger inclination toward dietary supplements and natural remedies, the growth of personalized care programs, and a demand for therapies targeting specific symptoms.

The menopause market size has grown strongly in recent years. It will grow from $18.78 billion in 2025 to $19.95 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to aging female population, increased life expectancy among women, widespread use of hormone replacement therapy, growing awareness of menopausal symptoms, expansion of women's healthcare services.

Download a free sample of the menopause market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13190&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Leading Companies Driving the Menopause Market Forward
The menopause market features several prominent players, including Pfizer Inc., Johnson & Johnson Inc., The Procter & Gamble Company, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A, Abbott Laboratories Ltd., GSK plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Cipla Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc., Rainbow Light Nutritional Systems LLC, Mithra Pharmaceuticals SA, TherapeuticsMD Inc., Theramex SpA, Pure Encapsulations LLC., Mylan N.V., and Serenity Pharmaceuticals LLC.

A notable recent development took place in December 2023 when Theramex HQ UK Limited, a global specialty pharmaceutical firm focused on women's health, acquired the Femoston and Duphaston hormone replacement therapy portfolio in Europe from Viatris Inc. This acquisition aims to enhance Theramex's position by increasing access to well-established hormone replacement therapies for managing menopausal symptoms across various European markets. Viatris Inc., a US-based pharmaceutical company, previously held the European rights for these products.

View the full menopause market report:
https://www.thebusinessresearchcompany.com/report/menopause-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Emerging Trends Creating New Horizons in the Menopause Sector
In the search for innovative, hormone-free treatment options, many companies are developing therapies like dual neurokinin 1/neurokinin 3 (NK1/NK3) receptor antagonists. These drugs offer relief from vasomotor symptoms such as hot flashes and night sweats by targeting neuropeptide pathways that control body temperature and sweat responses, improving quality of life for menopausal women without relying on hormones.

For instance, Bayer AG, headquartered in Germany, received FDA approval in October 2025 for Lynkuet (elinzanetant) 60 mg capsules, the first dual-NK1/NK3 receptor antagonist approved globally for treating moderate to severe hot flashes associated with menopause. Lynkuet provides once-daily bedtime dosing, significantly reduces hot flash frequency and severity as demonstrated in three Phase III clinical trials (OASIS 1/2/3), and offers a non-hormonal treatment approach that expands options for women who cannot undergo hormone therapy.

Largest Market Segments Defining the Menopause Industry
This report segments the menopause market into several categories:
1) By Treatment: Dietary Supplements and Over-The-Counter (OTC) Pharmaceutical Products
2) By Route of Administration: Topical, Oral, and Injectable forms
3) By Distribution Channel: Hospitals, Retail Outlets, and Online Pharmacies
4) By End User: Hospitals, Diagnostic Centers, Specialty Clinics, and other user groups

Further subcategories include:
- Dietary Supplements such as Herbal Supplements, Vitamins and Minerals, Phytoestrogens, Omega-3 Fatty Acids, and Probiotics
- OTC Pharma Products including Hormone Replacement Therapy (HRT), Non-Hormonal OTC Products, Antidepressants for mood swings, Sleep aids, and Pain relievers

This segmentation highlights the diverse range of products and delivery methods catering to the varied needs of menopausal women worldwide.

Our latest 2026 market reports provide expanded strategic and visual intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, together with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.